Atopalm Hemorrhoidal
NDC Package 51141-0230-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Atopalm Hemorrhoidal is do not use if foil seal under cap is broken or missing. Marketed by Neopharm Usa, this product is identified by NDC 51141-0230 and is authorized under FDA application part346.

Identification & Billing

NDC Package Code
51141-0230-2
Package Description
1 TUBE in 1 CARTON / 56 g in 1 TUBE
Product Code
11-Digit Billing Format
51141023002
RxNorm Crosswalk
  • RxCUI: 1313818 - mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % Rectal Ointment
  • RxCUI: 1313818 - mineral oil 0.14 MG/MG / petrolatum 0.719 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment
  • RxCUI: 1313818 - mineral oil 14 % / petrolatum 71.9 % / phenylephrine hydrochloride 0.25 % Rectal Ointment
  • RxCUI: 1359113 - ATOPALM Hemorrhoidal 14 % / 71.9 % / 0.25 % Rectal Ointment
  • RxCUI: 1359113 - mineral oil 0.14 MG/MG / petrolatum 0.719 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment [Atopalm Hemorrhoidal]

Clinical Specifications

Proprietary Name
Atopalm Hemorrhoidal
Dosage Form
-
Usage Information
Do not use if foil seal under cap is broken or missing. ■ adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Gently dry by patting or blotting with a tissue or a soft cloth before applying ointment ■ when first opening the tube, puncture foil seal with top end of cap ■ apply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement ■ for intrarectal use, remove cover from the applicator, attach applicator to tube, lubricate applicator well, then gently insert applicator into the rectum ■ thoroughly cleanse applicator after each use and replace cover ■ also apply ointment to external area ■ regular use provides continual therapy for relief ofsymptoms ■ children under 12 years of age, ask a doctor.

Regulatory & Marketing

Labeler Name
Neopharm Usa
FDA Application #
part346
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
07-18-2012
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51141-0230-2 identifies a specific commercial package of 1 tube in 1 carton / 56 g in 1 tube of Atopalm Hemorrhoidal, labeled by Neopharm Usa. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neopharm Usa on July 18, 2012. The current certification is valid through December 31, 2017.

How is this Neopharm Usa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51141023002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51141-0230-2
11-Digit CMS (5-4-2)
51141-0230-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.